Publications

Publications

At Bayer, we are working in collaboration with the leading scientific, academic, and community partners to improve our understanding of cardiorenal diseases.  

 

We invite you to explore Bayer-supported publications pertaining to heart failure with a focus on LVEF ≥ 40%. This library is not intended to serve as a comprehensive repository of all publications. Publications not supported by Bayer are not included. Access to the full text of publications may depend on journal access rights.

 

To help narrow down your search, choose the relevant tags and click apply. Applying multiple tags will narrow your results.

 

Last updated April 20, 2026.

Types of Enhancements Available

audio
Audio
infographic
Graphical Abstract
PLS
Plain Language Summary
video
Video
other
Others

To help narrow down your search, select the relevant filters from the dropdowns and Click Apply

Hold down Ctrl key on keyboard to select multiple years

Total available publications: 97    

Filtered results: 97

Effects of Finerenone on Sudden Death Across the Cardio-Kidney-Metabolic Landscape: A FINE-HEART Analysis

Publication - Foa A, et al, JACC. 2026

Foa A, 08 06 2026

Mechanisms, Magnitude, and Consequence of Acute Estimated Glomerular Filtration Rate Change With Guideline-Directed Medical Therapy Initiation in Heart Failure

Publication - Shafi T., et al, AJC. 2026

Shafi T, 28 05 2026

Mineralocorticoid Receptor Antagonists for the Treatment of Heart Failure and Kidney Disease: A State-of-the-Art Review

Publication - Van Spall HGC., et al, HFR. 2026

Van Spall HGC, 20 05 2026

A Systematic Literature Search and Narrative Synthesis of Economic Drivers in Hospitalizations for Heart Failure With Preserved or Mildly Reduced Ejection Fraction in the United States

Publication - Stewart F., et al, AJMC. 2026

Stewart F, 12 05 2026

Viral respiratory tract infections in heart failure: the FINEARTS-HF trial

Publication - Helseth R., et al, EHJ. 2026

Helseth R, 11 05 2026

Geographic Variation in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: Insights From the FINEARTS-HF Trial

Publication - Makuvire T., et al, JACC:HF. 2026

Makuvire T, 08 05 2026

Effects of Finerenone Across a Range of Heart Failure Duration: A Prespecified Analysis of the FINEARTS-HF Trial

Hamatani Y., et al, EJHF. 2026

Hamatani Y, 05 05 2026

Finerenone, Liver Biomarkers, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction: An Analysis of FINEARTS-HF

Butt J., et al, CHF 2026

Butt J, 05 05 2026

Hyperaldosteronism in the Pathophysiology and Management of Cardiovascular-Kidney-Metabolic Syndrome

Publication - Zeitler E., et al, DOM. 2026

Zeitler E, 12 04 2026

Heart Failure and Comorbidities (Chronic Kidney Disease, Diabetes, Obesity) Management: A Multidisciplinary Approach

Abramov D. et al, CRM. 2026

Abramov D, 07 04 2026